Literatur
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico (1999) Dietary supplementation with n‑3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447–455
Bhatt DL, Steg G, Miller M et al (2018) Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. https://doi.org/10.1056/NEJMoa1812792
ASCEND Study Collaborative Group (2018) Effects of n‑3 fatty acid supplements in diabetes mellitus. N Engl J Med 379(16):1540–1550
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Preßler gibt an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Preßler, A. VITAL mit Omega-3 und Vitamin D? Zweifel an primärpräventivem Nutzen der beliebten Supplemente. Kardiologe 13, 5–7 (2019). https://doi.org/10.1007/s12181-018-0293-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12181-018-0293-y